Multifaceted evasion of the interferon response by cytomegalovirus

Journal of Interferon and Cytokine Research

Volumn 29, Issue 9, 2009, Pages 609-619

  Marshall, Emily E ^a,b   Geballe, Adam P ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYTOKINE; DOUBLE STRANDED RNA; IMMEDIATE EARLY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 9; INTERFERON STIMULATED GENE FACTOR 3; JANUS KINASE 1; LYMPHOTOXIN; LYMPHOTOXIN BETA RECEPTOR; PROTEIN KINASE R; RNA BINDING PROTEIN; STAT2 PROTEIN; SYNAPTOTAGMIN I; VIRUS PROTEIN;

CELL MEMBRANE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE ACTIVATION; GENE EXPRESSION; HERPES VIRUS; HOST RESISTANCE; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; RHESUS MONKEY; TRANSCRIPTION INITIATION; VIRION; VIRUS ENTRY; VIRUS REPLICATION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EIF-2 KINASE; HUMANS; IMMUNITY, INNATE; IMMUNOCOMPROMISED HOST; INFANT, NEWBORN; INTERFERON REGULATORY FACTORS; INTERFERONS; NF-KAPPA B; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS; VIRULENCE;

CERCOPITHECINE HERPESVIRUS 8; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1;

EID: 70349255946     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0064     Document Type: Review

References (79)

1. Abate DA, Watanabe S, Mocarski ES. 2004. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol 78(20):10995-11006. (Pubitemid 39299640)
2. Abenes G, Lee M, Haghjoo E, Tong T, Zhan X, Liu F. 2001. Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice. J Virol 75(4):1697-1707. (Pubitemid 32110159)
3. Banks TA, Rickert S, Benedict CA, Ma L, Ko M, Meier J, Ha W, Schneider K, Granger SW, Turovskaya O, Elewaut D, Otero D, French AR, Henry SC, Hamilton JD, Scheu S, Pfeffer K, Ware CF. 2005. A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection. J Immunol 174(11):7217-7225. (Pubitemid 40705690)
4. Baron M, Davignon JL. 2008. Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2. J Immunol 181(8):5530-5536.
5. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin H.W.T. 2007. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447(7142):326-329. (Pubitemid 46788830)
6. Benedict CA, Banks TA, Senderowicz L, Ko M, Britt WJ, Angulo A, Ghazal P, Ware CF. 2001. Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus detente. Immunity 15(4):617-626. (Pubitemid 33016446)
7. Bentz GL, Yurochko AD. 2008. Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc Natl Acad Sci USA 105(14):5531-5536.
8. Boehme KW, Guerrero M, Compton T. 2006. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 177(10):7094-7102. (Pubitemid 44715077)
9. Boyle KA, Pietropaolo RL, Compton T. 1999. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol Cell Biol 19(5):3607-3613. (Pubitemid 29193820)
10. Brocchieri L, Kledal TN, Karlin S, Mocarski ES. 2005. Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol 79(12):7570-7596. (Pubitemid 40756792)
11. Browne EP, Shenk T. 2003. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci USA 100(20):11439-11444. (Pubitemid 37205954)
12. Browne EP, Wing B, Coleman D, Shenk T. 2001. Altered cellular mRNA levels in human cytomegalovirus-infected fi broblasts: viral block to the accumulation of antiviral mRNAs. J Virol 75(24):12319-12330. (Pubitemid 33115904)
13. Budt M, Niederstadt L, Valchanova RS, Jonjic S, Brune W. 2009. Specifi c inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143. J Virol 83(3):1260-1270.
14. Cassady KA. 2005. Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection. J Virol 79(14):8707-8715.
15. Child SJ, Geballe AP. 2009. Binding and relocalization of protein kinase R by murine cytomegalovirus. J Virol 83(4):1790-1799.
16. Child SJ, Hakki M, De Niro KL, Geballe AP. 2004. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J Virol 78(1):197-205. (Pubitemid 37549732)
17. Child SJ, Hanson LK, Brown CE, Janzen DM, Geballe AP. 2006. Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. J Virol 80(20):10173-10180.
18. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW. 2003. Human cytomegalovirus activates infl amatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77(8):4588-4596. (Pubitemid 36402808)
19. DeFilippis V, Fruh K. 2005. Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3. J Virol 79(10):6419-6431. (Pubitemid 40617245)
20. DeFilippis VR, Robinson B, Keck TM, Hansen SG, Nelson JA, Fruh KJ. 2006. Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection. J Virol 80(2):1032-1037. (Pubitemid 43062914)
21. Delale T, Paquin A, Asselin-Paturel C, Dalod M, Brizard G, Bates EE, Kastner P, Chan S, Akira S, Vicari A, Biron CA, Trinchieri G, Brinre F. 2005. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo. J Immunol 175(10):6723-6732. (Pubitemid 41598916)
22. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identifi cation of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95(26):15623-15628.
23. Dever TE, Dar AC, Sicheri F. 2007. The eIF2alpha kinases. In: Matthews MB, Sonenberg N, Hershey JWB, eds. Translational control in biology and medicine. Cold Spring Harbor, NY: Cold Spring Harbor Press, pp 319-344.
24. Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MB. 2004. Does Toll-like receptor 3 play a biological role in virus infections Virology 322(2):231-238.
25. Gravel SP, Servant MJ. 2005. Roles of an IkappaB kinase-related pathway in human cytomegalovirus-infected vascular smooth muscle cells: a molecular link in pathogen-induced proatherosclerotic conditions. J Biol Chem 280(9):7477-7486.
26. Hakki M, Geballe AP. 2005. Double-stranded RNA binding by human cytomegalovirus pTRS1. J Virol 79(12):7311-7318. (Pubitemid 40756766)
27. Hakki M, Marshall EE, De Niro KL, Geballe AP. 2006. Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. J Virol 80(23):11817-11826. (Pubitemid 44788893)
28. Hanson LK, Dalton BL, Cageao LF, Brock RE, Slater JS, Kerry JA, Campbell AE. 2005. Characterization and regulation of essential murine cytomegalovirus genes m142 and m143. Virology 334(2):166-177.
29. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B. 2003. Identifi cation of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424(6950):743-748. (Pubitemid 37021696)
30. Huh YH, Kim YE, Kim ET, Park JJ, Song MJ, Zhu H, Hayward GS, Ahn JH. 2008. Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J Virol 82(21):10444-10454. (Pubitemid 352691174)
31. Isaacson MK, Juckem LK, Compton T. 2008. Virus entry and innate immune activation. Curr Top Microbiol Immunol 325:85-100.
32. Jahn G, Scholl BC, Traupe B, Fleckenstein B. 1987. The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. J Gen Virol 68(Pt 5):1327-1337. (Pubitemid 17055257)
33. Juckem LK, Boehme KW, Feire AL, Compton T. 2008. Differential initiation of innate immune responses induced by human cytomegalovirus entry into fi broblast cells. J Immunol 180(7):4965-4977.
34. Knight DA, Waldman WJ, Sedmak DD. 1997. Human cytomegalovirus does not induce human leukocyte antigen class II expression on arterial endothelial cells. Transplantation 63(9):1366-1369.
35. Le VT, Trilling M, Wilborn M, Hengel H, Zimmermann A. 2008a. Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol 89(Pt 10):2416-2426.
36. Le VT, Trilling M, Zimmermann A, Hengel H. 2008b. Mouse cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and controls activation pathways of the IFN-beta enhanceosome. J Gen Virol 89(Pt 5):1131-1141.
37. Li X, Leung S, Qureshi S, Darnell JE, Jr, Stark GR. 1996. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J Biol Chem 271(10):5790-5794. (Pubitemid 26083918)
38. Lin A, Xu H, Yan W. 2007. Modulation of HLA expression in human cytomegalovirus immune evasion. Cell Mol Immunol 4(2):91-98.
39. Mack C, Sickmann A, Lembo D, Brune W. 2008. Inhibition of proinfl ammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci USA 105(8):3094-3099. (Pubitemid 351723673)
40. Marshall EE, Bierle CJ, Brune W, Geballe AP. 2009. Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J Virol 83(9):4112-4120.
41. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman JW, Sedmak DD. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 187(5):675-683. (Pubitemid 28115183)
42. Miller DM, Zhang Y, Rahill BM, Waldman WJ, Sedmak DD. 1999. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 162(10):6107-6113. (Pubitemid 29314971)
43. Miller G. 2009. Brain cancer. A viral link to glioblastoma Science 323(5910):30-31.
44. Mocarski ES, Shenk T, Pass RF. 2007. Cytomegaloviruses. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams & Wilkins. pp 2702-2772.
45. Mohr IJ, Peery T, Mathews MB. 2007. Protein synthesis and translational control during viral infection. In: Matthews MB, Sonenberg N, Hershey JWB, eds. Translational control in biology and medicine: Cold Spring Harbor, NY: Cold Spring Harbor Press, pp 545-599.
46. Murphy E, Shenk T. 2008. Human cytomegalovirus genome. Curr Top Microbiol Immunol 325:1-19.
47. Netterwald JR, Jones TR, Britt WJ, Yang SJ, McCrone IP, Zhu H. 2004. Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus. J Virol 78(12):6688-6691. (Pubitemid 38715965)
48. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. 2002. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 185(3):273-282. (Pubitemid 34107239)
49. Paulus C, Krauss S, Nevels M. 2006. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci USA 103(10):3840-3845. (Pubitemid 43376642)
50. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A. 2009. Cytomegalovirus and human immunosenescence. Rev Med Virol 19(1):47-56.
51. Powers C, DeFilippis V, Malouli D, Fruh K. 2008. Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325:333-359.
52. Presti RM, Pollock JL, Dal Canto AJ, OGuin AK, Virgin HWT. 1998. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 188(3):577-588.
53. Preston CM, Harman AN, Nicholl MJ. 2001. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 75(19):8909-8916. (Pubitemid 32851895)
54. Prichard MN, Jairath S, Penfold ME, St Jeor S, Bohlman MC, Pari GS. 1998. Identifi cation of persistent RNA-DNA hybrid structures within the origin of replication of human cytomegalovirus. J Virol 72(9):6997-7004. (Pubitemid 28377826)
55. Randolph-Habecker J, Iwata M, Geballe AP, Jarrahian S, Torok-Storb B. 2002. Interleukin-1-mediated inhibition of cytomegalovirus replication is due to increased IFN-beta production. J Interferon Cytokine Res 22(7):765-772. (Pubitemid 35034690)
56. Rawlinson WD, Farrell HE, Barrell BG. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70(12):8833-8849. (Pubitemid 26378467)
57. Reeves M, Sinclair J. 2008. Aspects of human cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 325:297-313.
58. Romanowski MJ, Shenk T. 1997. Characterization of the human cytomegalovirus irs1 and trs1 genes: a second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation. J Virol 71(2):1485-1496. (Pubitemid 27030324)
59. Schneider K, Loewendorf A, De Trez C, Fulton J, Rhode A, Shumway H, Ha S, Patterson G, Pfeffer K, Nedospasov SA, Ware CF, Benedict CA. 2008. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3(2):67-76. (Pubitemid 351201786)
60. Scholz M, Hamann A, Blaheta RA, Auth MK, Encke A, Markus BH. 1992. Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma. Hum Immunol 35(4):230-238.
61. Sedmak DD, Guglielmo AM, Knight DA, Birmingham DJ, Huang EH, Waldman WJ. 1994. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol 144(4):683-692. (Pubitemid 24172057)
62. Silverman RH. 2007. Viral encounters with 2,5-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81(23):12720-12729. (Pubitemid 350156909)
63. Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T, Fruh K. 2001. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci USA 98(13):7140-7145. (Pubitemid 32567916)
64. Soroceanu L, Akhavan A, Cobbs CS. 2008. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455(7211):391-395.
65. Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA. 2008. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol 325:397-415.
66. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, Mudd S, Shamel L, Sovath S, Goode J, Alexopoulou L, Flavell RA, Beutler B. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101(10):3516-3521. (Pubitemid 38338227)
67. Taylor RT, Bresnahan WA. 2005. Human cytomegalovirus immediate- early 2 gene expression blocks virus-induced beta interferon production. J Virol 79(6):3873-3877.
68. Taylor RT, Bresnahan WA. 2006a. Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaBdependent gene expression. J Virol 80(21):10763-10771.
69. Taylor RT, Bresnahan WA. 2006b. Human cytomegalovirus immediate- early 2 protein IE86 blocks virus-induced chemokine expression. J Virol 80(2):920-928.
70. Terhune SS, Schroer J, Shenk T. 2004. RNAs are packaged into human cytomegalovirus virions in proportion to their intracellular concentration. J Virol 78(19):10390-10398. (Pubitemid 39258364)
71. Upton JW, Kaiser WJ, Mocarski ES. 2008. Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem 283(25):16966-16970.
72. Valchanova RS, Picard-Maureau M, Budt M, Brune W. 2006. Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J Virol 80(20):10181-10190. (Pubitemid 44522611)
73. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa- Tolic L, Wang D, Camp DG, II, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA. 2004. Identifi cation of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78(20):10960-10966. (Pubitemid 39299636)
74. Wiertz EJ, Devlin R, Collins HL, Ressing ME. 2007. Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation. J Virol 81(9):4389-4396. (Pubitemid 46668635)
75. Yurochko AD, Huang ES. 1999. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J Immunol 162(8):4806-4816. (Pubitemid 29314884)
76. Zhu H, Cong JP, Mamtora G, Gingeras T, Shenk T. 1998. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci USA 95(24):14470-14475. (Pubitemid 28549391)
77. Zhu H, Cong JP, Shenk T. 1997. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc Natl Acad Sci USA 94(25):13985-13990. (Pubitemid 28009696)
78. Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S, Koszinowski U, Hengel H. 2005. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med 201(10):1543-1553. (Pubitemid 40721000)
79. Zucchini N, Bessou G, Traub S, Robbins SH, Uematsu S, Akira S, Alexopoulou L, Dalod M. 2008. Cutting edge: Overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J Immunol 180(9):5799-5803.